{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:27:18Z","timestamp":1789090038331,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1ZIABCO11374"],"award-info":[{"award-number":["1ZIABCO11374"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Cancer Research"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.bbmt.2015.01.022","type":"journal-article","created":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T02:33:43Z","timestamp":1422326023000},"page":"1037-1045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Matched Related and Unrelated Donor Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency"],"prefix":"10.1016","volume":"21","author":[{"given":"Jennifer","family":"Cuellar-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Parta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heardley","family":"Murdock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi H.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Moutsopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gea-Banacloche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis D.","family":"Hickstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2015.01.022_bib1","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jaci.2009.10.038","article-title":"Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome","volume":"124","author":"Engelhardt","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.bbmt.2015.01.022_bib2","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","article-title":"Combined immunodeficiency associated with DOCK8 mutations","volume":"361","author":"Zhang","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.01.022_bib3","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1182\/blood-2012-01-407098","article-title":"DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses","volume":"119","author":"Harada","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.01.022_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/bmt.2010.169","article-title":"Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation","volume":"46","author":"Gatz","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.01.022_bib5","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jaci.2012.12.663","article-title":"In DOCK8 deficiency donor cell engraftment post-genoidentical hematopoietic stem cell transplantation is possible without conditioning","volume":"131","author":"Al-Mousa","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.bbmt.2015.01.022_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1399-3046.2011.01641.x","article-title":"Successful bone marrow transplantation for DOCK8 deficient hyper IgE syndrome","volume":"16","author":"Metin","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2015.01.022_bib7","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jaci.2010.07.034","article-title":"Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency","volume":"126","author":"McDonald","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.bbmt.2015.01.022_bib8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0030-1265135","article-title":"Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation","volume":"222","author":"Bittner","year":"2010","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.bbmt.2015.01.022_bib9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaci.2011.03.025","article-title":"Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency","volume":"128","author":"Barlogis","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.bbmt.2015.01.022_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/08880018.2012.714844","article-title":"Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen","volume":"29","author":"Boztug","year":"2012","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.bbmt.2015.01.022_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jaci.2014.02.023","article-title":"Flow cytometry diagnosis of dedicator of cytokinesis 8 (DOCK8) deficiency","volume":"134","author":"Pai","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.bbmt.2015.01.022_bib12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbmt.2005.12.028","volume":"12","author":"Kletzel","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.01.022_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/bmt.2009.133","article-title":"Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen","volume":"45","author":"Beri","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.01.022_bib14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.bbmt.2011.01.013","article-title":"Busulfan dosing in children with BMIs >\/= 85% undergoing HSCT: a new optimal strategy","volume":"17","author":"Browning","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.01.022_bib15","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","article-title":"Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins","volume":"32","author":"Bollard","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.01.022_bib16","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1084\/jem.20110345","article-title":"DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice","volume":"208","author":"Randall","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2015.01.022_bib17","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/ni.2305","article-title":"DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation","volume":"13","author":"Jabara","year":"2012","journal-title":"Nat Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.bbmt.2015.01.022_bib18","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/sj.bmt.1704846","article-title":"Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning","volume":"35","author":"Veys","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.01.022_bib19","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1182\/blood-2010-10-312082","article-title":"Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience","volume":"117","author":"Slatter","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.01.022_bib20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jaci.2012.12.1568","article-title":"Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency","volume":"131","author":"Mizesko","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.bbmt.2015.01.022_bib21","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1182\/blood-2004-02-0414","article-title":"Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS","volume":"104","author":"de Lima","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.01.022_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/bbmt.2002.v8.pm12374451","article-title":"Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes","volume":"8","author":"Russell","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.01.022_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbmt.2006.08.037","article-title":"Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule","volume":"13","author":"Madden","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.01.022_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbmt.2007.10.028","article-title":"High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen","volume":"14","author":"Geddes","year":"2008","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:51:21Z","timestamp":1761058281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879115000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1083879115000889"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.01.022","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Matched Related and Unrelated Donor Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}